Clinical Trials Directory

Trials / Completed

CompletedNCT05787899

Hypothermia's Effect on Hepatitis B Vaccination

Efficacy of the Hepatitis B Vaccination Post Hypothermia for Hypoxic Ischemic Encephalopathy

Status
Completed
Phase
Study type
Observational
Enrollment
9 (actual)
Sponsor
Medical University of South Carolina · Academic / Other
Sex
All
Age
0 Hours – 72 Hours
Healthy volunteers
Not accepted

Summary

The purpose of the research is to determine if the Hepatitis B vaccine after birth provides enough protection after cooling for Hypoxic Ischemic Encephalopathy (HIE). To do this, Hepatitis B titers (blood sample) would be taken before, during, and after administering of the Hepatitis B vaccine series to measure efficacy of the vaccine.

Detailed description

Despite the current research on Hypoxic Ischemic Encephalopathy (HIE), and the known effects of hypothermia on acute immune response, the effect of the hypothermia protocol for HIE on the efficacy of the Hepatitis B vaccine is still unknown. We plan to measure anti-hepatitis B surface antibodies at intervals prior, during, and after the primary Hepatitis B vaccine schedule for individuals with HIE to see if there is any effect on efficacy due to the Hypothermia protocol.

Conditions

Interventions

TypeNameDescription
OTHERHypothermia ProtocolSubject's who will be treated with the hypothermia protocol for Hypoxic Ischemic Encephalopathy as standard of care.

Timeline

Start date
2023-05-18
Primary completion
2024-10-01
Completion
2024-10-01
First posted
2023-03-28
Last updated
2024-10-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05787899. Inclusion in this directory is not an endorsement.